Gregersen P K
Department of Medicine, North Shore University Hospital, Cornell University Medical College, Manhasset, New York 11030.
Lab Invest. 1989 Jul;61(1):5-19.
Our understanding of HLA class II polymorphism has undergone a rapid evolution in the last few years. As in so many areas of modern biology, this progress has depended largely on the application of recombinant DNA techniques to the study of this gene family. In particular, the recent development of methods of gene amplification by means of the polymerase chain reaction has allowed for the rapid assessment of polymorphism in the human population. In addition, the elucidation by x-ray crystallographic analysis of the three-dimensional structure of an HLA molecule has been a major step. These areas of progress have now begun to converge to allow a more detailed approach to the problem of class II polymorphism and disease susceptibility. As discussed in this review, the data so far indicate that a few amino acid substitutions in class II molecules may exert a critical influence on susceptibility to autoimmune diseases such as RA and IDDM. The mechanism by which these class II polymorphisms predispose to autoimmune disease is still unknown. It is tempting to speculate that differences in the binding affinity of HLA molecules for autoantigens might be involved; however, as yet no specific autoantigen has been identified for either RA or IDDM. Intriguingly, sequence similarities have been observed between some viral proteins and class II molecules, raising the possibility that these infectious agents might induce autoimmunity by "molecular mimicry." Examples include the human cytomegalovirus protein, IE2 as well as the Epstein Barr virus gp110 protein. Other possible mechanisms involve more complex immunoregulatory effects, such as the absence of suppressor functions that appear to be under the influence of the HLA genes. To some extent, the persistent ignorance about the cause of autoimmunity reflects a general lack of knowledge concerning exactly how HLA polymorphisms exert immunoregulatory effects. For example, in addition to influencing antigen presentation, MHC molecules also affect the overall T cell repertoire during thymic selection. The relative importance of HLA class II polymorphism in exerting immunoregulatory effects by means of thymic selection of the T cell repertoire is unknown. For autoimmune diseases such as RA and IDDM, there is a need to identify a specific functional abnormality that is causing the disease before the etiological significance of the emerging associations with class II polymorphisms become clear.(ABSTRACT TRUNCATED AT 400 WORDS)
在过去几年中,我们对HLA II类多态性的理解经历了快速演变。与现代生物学的许多领域一样,这一进展在很大程度上依赖于重组DNA技术在该基因家族研究中的应用。特别是,最近通过聚合酶链反应进行基因扩增方法的发展,使得能够快速评估人类群体中的多态性。此外,通过X射线晶体学分析阐明HLA分子的三维结构是一个重要步骤。这些进展领域现在开始汇聚,以便对II类多态性和疾病易感性问题采取更详细的方法。如本综述中所讨论的,迄今为止的数据表明,II类分子中的一些氨基酸取代可能对类风湿性关节炎(RA)和胰岛素依赖型糖尿病(IDDM)等自身免疫性疾病的易感性产生关键影响。这些II类多态性导致自身免疫性疾病的机制仍然未知。有人推测,HLA分子与自身抗原的结合亲和力差异可能与之有关;然而,目前尚未确定RA或IDDM的特异性自身抗原。有趣的是,在一些病毒蛋白和II类分子之间观察到序列相似性,这增加了这些感染因子可能通过“分子模拟”诱导自身免疫的可能性。例子包括人类巨细胞病毒蛋白IE2以及爱泼斯坦-巴尔病毒gp110蛋白。其他可能的机制涉及更复杂的免疫调节作用,例如似乎受HLA基因影响的抑制功能缺失。在某种程度上,对自身免疫病因的持续无知反映了对HLA多态性究竟如何发挥免疫调节作用普遍缺乏了解。例如,除了影响抗原呈递外,MHC分子在胸腺选择过程中也会影响整体T细胞库。HLA II类多态性通过胸腺选择T细胞库发挥免疫调节作用的相对重要性尚不清楚。对于RA和IDDM等自身免疫性疾病,在与II类多态性新出现的关联的病因学意义变得明确之前,需要确定导致该疾病的特定功能异常。(摘要截短至400字)